An AI algorithm that reportedly helps physicians identify reduced left ventricular ejection fraction (LVEF) received Breakthrough Device designation from the FDA on Dec. 18.

A study funded by the Mayo Clinic and published in Circulation: Arrhythmia and Electrophysiology this week suggests AI could be successfully applied to ECG data to measure a person’s overall health status.

Cardiologists discuss the questions and concerns swirling around the thriving wearables market as patients strap on a variety of smart devices and expect their physicians to catch up.

A team of University of Texas at Austin researchers are looking to replace the decades-old electrocardiography process with a more comprehensive, streamlined way to monitor heart health: e-tattoos.

AliveCor has been granted FDA clearance for KardiaMobile 6L, the world’s first publicly available six-lead personal electrocardiogram device.

Omron Healthcare launched its latest innovation, Complete, May 1, marking the first time a blood pressure (BP) monitor with electrocardiogram (ECG) capabilities has hit the commercial market.

A deep learning model trained on more than 1.5 million electrocardiograms can reliably detect hyperkalemia—or abnormally high potassium levels in the blood—among patients with chronic kidney disease (CKD), Mayo Clinic researchers reported April 3 in JAMA Cardiology.

Electrocardiograms (ECG) acquired using a chest strap could be a quality alternative to traditional ECGs when used to diagnose atrial fibrillation (AF), researchers reported in the American Journal of Cardiology.